Martin & Co. Inc. TN lowered its position in McKesson Co. (NYSE:MCK) by 3.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,195 shares of the company’s stock after selling 920 shares during the period. McKesson accounts for 1.2% of Martin & Co. Inc. TN’s portfolio, making the stock its 26th largest holding. Martin & Co. Inc. TN’s holdings in McKesson were worth $3,563,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of MCK. BlackRock Inc. increased its holdings in shares of McKesson by 8.0% in the second quarter. BlackRock Inc. now owns 15,330,001 shares of the company’s stock valued at $2,522,396,000 after purchasing an additional 1,131,024 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of McKesson by 0.4% in the second quarter. Vanguard Group Inc. now owns 14,090,544 shares of the company’s stock valued at $2,318,457,000 after purchasing an additional 62,004 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of McKesson by 6.5% in the third quarter. Bank of New York Mellon Corp now owns 2,540,305 shares of the company’s stock valued at $390,217,000 after purchasing an additional 154,967 shares in the last quarter. Pzena Investment Management LLC increased its holdings in shares of McKesson by 17.2% in the third quarter. Pzena Investment Management LLC now owns 2,458,531 shares of the company’s stock valued at $377,655,000 after purchasing an additional 360,676 shares in the last quarter. Finally, Wells Fargo & Company MN increased its holdings in shares of McKesson by 12.7% in the second quarter. Wells Fargo & Company MN now owns 2,121,171 shares of the company’s stock valued at $349,017,000 after purchasing an additional 239,358 shares in the last quarter. Institutional investors own 88.10% of the company’s stock.

A number of analysts recently weighed in on MCK shares. BidaskClub lowered shares of McKesson from a “sell” rating to a “strong sell” rating in a report on Saturday, August 19th. TheStreet lowered shares of McKesson from a “b” rating to a “c+” rating in a report on Friday, August 25th. Jefferies Group set a $165.00 price target on shares of McKesson and gave the company a “hold” rating in a report on Tuesday, August 29th. Needham & Company LLC raised shares of McKesson from a “hold” rating to a “buy” rating and set a $179.00 price target for the company in a report on Friday, September 8th. Finally, Morgan Stanley lowered shares of McKesson from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $184.00 to $172.00 in a report on Thursday, September 14th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $174.31.

In other news, CEO John H. Hammergren sold 125,000 shares of McKesson stock in a transaction on Wednesday, September 20th. The shares were sold at an average price of $150.18, for a total transaction of $18,772,500.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO John H. Hammergren sold 100,000 shares of McKesson stock in a transaction on Monday, September 25th. The stock was sold at an average price of $154.15, for a total transaction of $15,415,000.00. Following the transaction, the chief executive officer now directly owns 165,000 shares in the company, valued at $25,434,750. The disclosure for this sale can be found here. Over the last three months, insiders have sold 949,000 shares of company stock worth $145,263,360. Insiders own 1.20% of the company’s stock.

McKesson Co. (NYSE:MCK) traded up $0.74 on Wednesday, reaching $154.55. 1,981,400 shares of the company’s stock were exchanged, compared to its average volume of 1,875,875. The firm has a market cap of $32,065.46, a price-to-earnings ratio of 12.65, a PEG ratio of 1.58 and a beta of 1.23. McKesson Co. has a 12-month low of $133.82 and a 12-month high of $169.29. The company has a quick ratio of 0.61, a current ratio of 1.05 and a debt-to-equity ratio of 0.66.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Thursday, October 26th. The company reported $3.28 earnings per share for the quarter, topping analysts’ consensus estimates of $2.78 by $0.50. The company had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.69 billion. McKesson had a net margin of 2.24% and a return on equity of 24.87%. The business’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period last year, the firm posted $2.94 earnings per share. equities analysts forecast that McKesson Co. will post 12.17 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, January 2nd. Stockholders of record on Friday, December 1st will be given a dividend of $0.34 per share. The ex-dividend date is Thursday, November 30th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.88%. McKesson’s dividend payout ratio is 6.45%.

TRADEMARK VIOLATION NOTICE: “McKesson Co. (MCK) Shares Sold by Martin & Co. Inc. TN” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/12/13/mckesson-co-mck-shares-sold-by-martin-co-inc-tn.html.

About McKesson

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Stock Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related stocks with our FREE daily email newsletter.